Grifols S.A. American Depositary Shares (GRFS)
Stock · NASDAQ · Health Care
$7.69as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$7.85
Industry
Biotechnology: Pharmaceutical Preparations
About GRFS
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmo…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 25,258
- Website
- www.grifols.com/
Fundamentals
- 1-day range
- $7.68$7.89
- Market cap
- $5.40B
- P/E (trailing)
- 13.31
- P/E (forward)
- 5.39
- EPS (trailing)
- $0.67
- Dividend yield
- 3.62%
- Beta
- 0.84
- Avg. volume
- 641.0K
- Ex-dividend date
- July 2, 2026
- Dividend pay date
- July 9, 2026
52-week range
$8.43$12.87
Next earnings: February 25, 2027confirmed
Forecasts
2 analyst ratings
Buy 67%
Hold 24%
Sell 10%
1-year price forecast
High
$11.73
+52.5%
Median
$10.87
+41.3%
Low
$10
+30.0%
Grifols S.A. American Depositary Shares Competitors
Chosen by industry and closest market cap.
- GRFSGrifols S.A. American Depositary Shares$7.68▼ 1.79%Market cap $5.40BP/E 13.31$8.43$12.87
- PTCTPTC Therapeutics Inc. Common Stock$70.01▼ 2.51%Market cap $5.68BP/E —$48.86$90.87
- KNSAKiniksa Pharmaceuticals International plc Class A Ordinary Shares$78.1▼ 2.13%Market cap $5.73BP/E 75.29$33.25$82.94
- DNTHDianthus Therapeutics Inc. Common Stock$105.72▼ 5.22%Market cap $5.80BP/E —$22.81$117.88
- LGNDLigand Pharmaceuticals Incorporated Common Stock$280▼ 1.59%Market cap $5.85BP/E 38.07$158.4$326.63
- BLTEBelite Bio Inc American Depositary Shares$151.65▼ 3.42%Market cap $6.09BP/E —$62.18$200
- ERASErasca Inc. Common Stock$18.03▼ 7.49%Market cap $6.11BP/E —$1.33$24.28
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GRFS Grifols S.A. American Depositary Shares | $5.40B | 13.31 | $7.68 | ▼ 1.79% | $8.43$12.87 |
| PTCT PTC Therapeutics Inc. Common Stock | $5.68B | — | $70.01 | ▼ 2.51% | $48.86$90.87 |
| KNSA Kiniksa Pharmaceuticals International plc Class A Ordinary Shares | $5.73B | 75.29 | $78.1 | ▼ 2.13% | $33.25$82.94 |
| DNTH Dianthus Therapeutics Inc. Common Stock | $5.80B | — | $105.72 | ▼ 5.22% | $22.81$117.88 |
| LGND Ligand Pharmaceuticals Incorporated Common Stock | $5.85B | 38.07 | $280 | ▼ 1.59% | $158.4$326.63 |
| BLTE Belite Bio Inc American Depositary Shares | $6.09B | — | $151.65 | ▼ 3.42% | $62.18$200 |
| ERAS Erasca Inc. Common Stock | $6.11B | — | $18.03 | ▼ 7.49% | $1.33$24.28 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Oakmark International Small Cap Strategy Q2 2026 Portfolio UpdateSeekingAlpha · 8/15/2026
- Grifols Announces Completion Of Follow-Up For All 345 Patients In Phase 3 SPARTA Trial Of Prolastin-C In Alpha-1 Emphysema; Topline Data Expected By End Of 2026benzinga · 8/10/2026
- European Equities Traded in the US as American Depositary Receipts Edge Up in Wednesday TradingYahoo · 8/5/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 140.88M
- Total value held
- $1.13B
- Institutional holders
- 183
Top holders this quarter
- Unknown36.33M
- Unknown22.92M
- Unknown19.35M
- Unknown8.39M
- Unknown5.01M
- Unknown4.33M
- Unknown3.29M
- Unknown3.16M
- Unknown2.99M
- Unknown2.86M
See the full, filterable feed with live charts on the MarketWall dashboard.